Cellzome is a privately-owned drug discovery company identifying a new generation of kinase targeted drugs to treat inflammatory diseases.
Latest News
- March 2009: Cellzome Announces Achievement of Second and Third Milestones in Inflammation Alliance with GlaxoSmithKline [+]
- December 2008: Cellzome Announces Achievement of First Milestone in Inflammation Alliance with GlaxoSmithKline [+]
- November 2008: Cellzome awarded € 3.85m grant in Germany's High-Tech Initiative
to Fund Top Regional Clusters [+]
Meet Cellzome at ... [+]